Αρχειοθήκη ιστολογίου

Τρίτη 5 Απριλίου 2016

Asymmetric hearing loss is common and benign in patients aged 95 years and older.

Related Articles

Asymmetric hearing loss is common and benign in patients aged 95 years and older.

Laryngoscope. 2016 Apr 4;

Authors: Leskowitz MJ, Caruana FF, Siedlecki B, Qian ZJ, Spitzer JB, Lalwani AK

Abstract
OBJECTIVES/HYPOTHESIS: The objective of our study was to investigate age-specific auditory function in the patient population aged 95 years and older.
STUDY DESIGN: Retrospective chart review at a tertiary medical center.
METHODS: Medical records of 51 patients older than 95 years (82% female, 18% male) who underwent audiologic testing were reviewed. The following information was collected: age at time of most recent audiogram and prior audiograms; results of pure tone, immittance, and speech audiometry; and findings on radiologic imaging.
RESULTS: None of the subjects had hearing in the normal range. For the poorer hearing ear, average low-frequency, high-frequency, and overall pure tone averages (PTA) for the population were 67.9, 82.1, and 74.9 dB hearing level, respectively. Mean word recognition score (WRS) was 57.6% and deteriorated with increasing PTA (P = .0002). Asymmetry, defined by a 10-dB difference at two frequencies, was present in 39.2% of the sample, and WRS asymmetry, defined as a difference of 12% in WRS between ears, was present in 33.0% of the sample. Retrocochlear evaluation did not identify pathology in any of the cases tested. In the poorer hearing ear, average decline in PTA per year was 2.9 dB.
CONCLUSIONS: In individuals >95 years of age, hearing loss was universal, moderately severe to profound in magnitude, and associated with substantial loss of speech recognition. Hearing loss progresses at a rate greater than for younger cohorts. In this "oldest old" population, asymmetry of loss and WRS was common and is not indicative of retrocochlear pathology.
LEVEL OF EVIDENCE: 4 Laryngoscope, 2016.

PMID: 27040356 [PubMed - as supplied by publisher]



from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/1VtVZ3R
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου